Nasdaq
LEGN
Legend Biotech Corporation
- Health Care
- Listed 2020
- 1 day
- +1.2%
- 1 month
- −30.3%
- 1 year
- −48.8%
$19.28 · Mkt cap $3.58B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Legend Biotech Corporation
$19.28 · Mkt cap $3.58B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Legend Biotech Corporation trades under the ticker LEGN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $3.58B. The last closing price was $19.28, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −48.8%, and −30.3% over the past month. Returns are price returns and exclude dividends.
This page exists because LEGN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.